ArriVent BioPharma Inc. Company Profile
NASDAQ: AVBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
16.89+1.80 (+11.93%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 17.10 +1.24%
ArriVent BioPharma at a glance
ArriVent BioPharma Inc. (NASDAQ: AVBP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2024. At a market capitalization of $744.1 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001868279, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- ArriVent BioPharma Inc.
- Ticker
- NASDAQ: AVBP
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2024
- Market cap
- $744.05M
- SEC CIK
- 0001868279
Companies similar to ArriVent BioPharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GYREGyre Therapeutics Inc. | 7.04 | -0.56% | $746.48M | vs AVBP |
| VSTMVerastem Inc. | 8.27 | +6.65% | $748.51M | vs AVBP |
| APMDApnimed Inc. | 18.04 | -3.27% | $751.02M | vs AVBP |
| DSGNDesign Therapeutics Inc. | 11.69 | -2.34% | $731.58M | vs AVBP |
| AVTXAvalo Therapeutics Inc. | 13.58 | -0.07% | $728.30M | vs AVBP |
| ANNXAnnexon Inc. | 4.01 | -0.50% | $760.21M | vs AVBP |
| HELPHelus Pharma Inc. | 10.51 | -2.32% | $767.86M | vs AVBP |
| GERNGeron Corporation | 1.20 | -0.83% | $770.97M | vs AVBP |